New Cardiovascular Horizons (NCVH) 2017
Avatar

Zilver PTX Drug-Eluting Stent: Hard to Argue With Initial and 5-Year Results

By New Cardiovascular Horizons (NCVH) 2017 FEATURING Carlos Mena
By New Cardiovascular Horizons (NCVH) 2017 FEATURING Carlos Mena
44 views
September 18, 2017
0 Comments
Login to view comments. Click here to Login

Featured Video

10:19
Boston Scientific

What are we getting wrong with vessel preparation?

Feat. S. Steiner

Related Content

AUTOPLAY
02:37
Boston Scientific

Drug-Eluting Stents: The Heritage

Feat. G. Ansel, M. Jaff, R. Lookstein, J. Diaz-Cartelle
03:13
Boston Scientific

Drug-Eluting Stents: The Breakthrough

Feat. A. Holden, W. Gray, R. Lookstein, T. Zeller
03:43
Boston Scientific

The Design of a Drug-Eluting Stent System

02:12
Boston Scientific

IMPERIAL Trial: Influencing Treatment Algorithms

Feat. S. Henao, M. Jaff, W. Gray, R. Lookstein, G. Ansel
01:46
Boston Scientific

The Challenges of the SFA

02:37
Boston Scientific

Drug-Eluting Stents: The Challenge

Feat. L. Garcia, M. Jaff, R. Lookstein
01:40
Boston Scientific

IMPERIAL Trial: First of its Kind Design

Feat. W. Gray, R. Lookstein, M. Jaff
14:09
ARCH Advanced Revascularization Symposium

What Is the Future of Drug-Eluting Technologies?

Feat. E. Dippel
01:02
Boston Scientific

Dr. Lookstein IMPERIAL 2-Year Data

Feat. R. Lookstein
02:28
Boston Scientific

Impact of the IMPERIAL Trial

Feat. M. Jaff, W. Gray, R. Lookstein, S. Henao, G. Ansel
03:20
Boston Scientific

Drug-Eluting Stents: The Solution

Feat. J. Granada, M. Montero-Baker, A. Holden, G. Ansel
52
Boston Scientific

Boston Scientific Drug-Eluting Technologies

Feat. R. Sachar
02:58
Boston Scientific

Drug-Eluting Stents: The Data

Feat. J. Diaz-Cartelle, R. Lookstein, L. Garcia
31:09
Boston Scientific

Contemporary Controversies in Drug Eluting Technologies for Femoropo…

Feat. E. Secemsky, A. Dua, E. Genovese
23:45
NY Endovascular Summit

Subacute Occlusion Left SFA - Leipzig, Germany - LINC 2019

Feat. A. Schmidt
10:25
NY Endovascular Summit

Drug-Eluting Technology for Below-the-Knee Intervention

Feat. M. Bunte
17:27
ARCH Advanced Revascularization Symposium

Paclitaxel or Limus: What Is the Future in Drug Eluting Therapies?

Feat. C. Walker
20:01
ARCH Advanced Revascularization Symposium

What Stent to Use 2019

Feat. J. Singh
06:48
New Cardiovascular Horizons (NCVH)

Sirolimus Eluting Stents BTK: Outcomes and Safety

Feat. S. Khan
09:29
Boston Scientific

Clinical Update in Drug Eluting Technologies for PAD

Feat. P. Monteleone